Drug Manufacturers - Specialty & Generic · Healthcare
CFO
2025-05-30–2026-09-29
Erick J. Frim
Equibles does not estimate personal net worth.
About Erick J. Frim
Earlier roles on record: CFO at Apimeds Pharmaceuticals US, Inc. (APUS) until September 29, 2026 and CFO at Apimeds Pharmaceuticals US, Inc. (APUS) until March 20, 2026. Apimeds Pharmaceuticals US, Inc. reported in an 8-K filed October 1, 2026 that Erick J. Frim resigned as Interim Chief Financial Officer, effective September 29, 2026. Apimeds Pharmaceuticals US, Inc. reported in an 8-K filed March 25, 2026 that Erick J. Frim was terminated as Chief Financial Officer, effective March 20, 2026. Apimeds Pharmaceuticals US, Inc. reported in an 8-K filed June 5, 2025 that Erick J. Frim was appointed Chief Financial Officer, effective May 30, 2025.
“On September 29, 2026, Erick Frim notified Apimeds Pharmaceuticals US, Inc., a Delaware corporation (the "Company"), of his resignation as Interim Chief Financial Officer of the Company, effective immediately.”
“the Board removed Mr. Erick Frim as Chief Financial Officer of the Company and from all other positions held at the Company and its subsidiaries, effective immediately.”
Affiliation history
-
2025-05-30–2026-03-20
-
2025-05-30–2026-09-29